Annual Current Liabilities
$37.81 M
+$15.30 M+67.98%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual total current liabilities is $37.81 million, with the most recent change of +$15.30 million (+67.98%) on December 31, 2023.
- During the last 3 years, PRQR annual current liabilities has risen by +$25.14 million (+198.41%).
- PRQR annual current liabilities is now at all-time high.
Performance
PRQR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$44.27 M
+$4.31 M+10.80%
September 1, 2024
Summary
- As of February 7, 2025, PRQR quarterly total current liabilities is $44.27 million, with the most recent change of +$4.31 million (+10.80%) on September 1, 2024.
- Over the past year, PRQR quarterly current liabilities has increased by +$16.07 million (+56.96%).
- PRQR quarterly current liabilities is now at all-time high.
Performance
PRQR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PRQR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.0% | +57.0% |
| 3 y3 years | +198.4% | +67.0% |
| 5 y5 years | +305.1% | +67.0% |
PRQR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.0% | at high | +136.6% |
| 5 y | 5-year | at high | +207.0% | at high | +338.6% |
| alltime | all time | at high | >+9999.0% | at high | +1272.8% |
ProQR Therapeutics NV Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.27 M(+10.8%) |
| Jun 2024 | - | $39.96 M(+7.5%) |
| Mar 2024 | - | $37.17 M(-1.7%) |
| Dec 2023 | $37.81 M(+68.0%) | $37.81 M(+34.0%) |
| Sep 2023 | - | $28.21 M(+13.0%) |
| Jun 2023 | - | $24.97 M(+33.4%) |
| Mar 2023 | - | $18.71 M(-16.9%) |
| Dec 2022 | $22.51 M(-28.0%) | $22.51 M(-15.1%) |
| Sep 2022 | - | $26.51 M(-6.5%) |
| Jun 2022 | - | $28.35 M(+7.1%) |
| Mar 2022 | - | $26.47 M(-15.3%) |
| Dec 2021 | $31.24 M(+146.6%) | $31.24 M(-22.3%) |
| Sep 2021 | - | $40.23 M(+173.2%) |
| Jun 2021 | - | $14.73 M(+19.7%) |
| Mar 2021 | - | $12.30 M(-2.9%) |
| Dec 2020 | $12.67 M(+2.9%) | $12.67 M(-0.2%) |
| Sep 2020 | - | $12.70 M(+25.0%) |
| Jun 2020 | - | $10.16 M(+0.6%) |
| Mar 2020 | - | $10.10 M(-18.0%) |
| Dec 2019 | $12.31 M | $12.31 M(+1.1%) |
| Sep 2019 | - | $12.18 M(+18.4%) |
| Jun 2019 | - | $10.29 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $10.89 M(+16.6%) |
| Dec 2018 | $9.33 M(-8.4%) | $9.33 M(-21.7%) |
| Sep 2018 | - | $11.93 M(+17.4%) |
| Jun 2018 | - | $10.16 M(+16.3%) |
| Mar 2018 | - | $8.74 M(-14.3%) |
| Dec 2017 | $10.19 M(+43.7%) | $10.19 M(+35.7%) |
| Sep 2017 | - | $7.51 M(+18.9%) |
| Jun 2017 | - | $6.31 M(-9.8%) |
| Mar 2017 | - | $7.00 M(-1.3%) |
| Dec 2016 | $7.09 M(+18.3%) | $7.09 M(-18.5%) |
| Sep 2016 | - | $8.71 M(+1.2%) |
| Jun 2016 | - | $8.60 M(+25.3%) |
| Mar 2016 | - | $6.87 M(+14.5%) |
| Dec 2015 | $6.00 M(+63.6%) | $6.00 M(+10.8%) |
| Sep 2015 | - | $5.42 M(-6.4%) |
| Jun 2015 | - | $5.79 M(+12.2%) |
| Mar 2015 | - | $5.16 M(+40.8%) |
| Dec 2014 | $3.67 M(-26.3%) | $3.67 M(+9.7%) |
| Sep 2014 | - | $3.34 M(+3.6%) |
| Jun 2014 | - | $3.23 M(-35.2%) |
| Dec 2013 | $4.97 M(+2530.3%) | $4.97 M |
| Dec 2012 | $189.10 K | - |
FAQ
- What is ProQR Therapeutics NV annual total current liabilities?
- What is the all time high annual current liabilities for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual current liabilities year-on-year change?
- What is ProQR Therapeutics NV quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly current liabilities year-on-year change?
What is ProQR Therapeutics NV annual total current liabilities?
The current annual current liabilities of PRQR is $37.81 M
What is the all time high annual current liabilities for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual total current liabilities is $37.81 M
What is ProQR Therapeutics NV annual current liabilities year-on-year change?
Over the past year, PRQR annual total current liabilities has changed by +$15.30 M (+67.98%)
What is ProQR Therapeutics NV quarterly total current liabilities?
The current quarterly current liabilities of PRQR is $44.27 M
What is the all time high quarterly current liabilities for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly total current liabilities is $44.27 M
What is ProQR Therapeutics NV quarterly current liabilities year-on-year change?
Over the past year, PRQR quarterly total current liabilities has changed by +$16.07 M (+56.96%)